AERSALE CORP (ASLE) Fundamental Analysis & Valuation

NASDAQ:ASLE • US00810F1066

6.105 USD
-0.33 (-5.2%)
Last: Mar 12, 2026, 02:24 PM

This ASLE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

ASLE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 78 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of ASLE have multiple concerns. ASLE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. ASLE Profitability Analysis

1.1 Basic Checks

  • ASLE had positive earnings in the past year.
  • ASLE had a positive operating cash flow in the past year.
  • In multiple years ASLE reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ASLE reported negative operating cash flow in multiple years.
ASLE Yearly Net Income VS EBIT VS OCF VS FCFASLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

  • ASLE has a Return On Assets (0.91%) which is in line with its industry peers.
  • ASLE has a Return On Equity (1.41%) which is in line with its industry peers.
  • ASLE has a Return On Invested Capital (1.78%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.91%
ROE 1.41%
ROIC 1.78%
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ASLE Yearly ROA, ROE, ROICASLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

  • ASLE has a Profit Margin (1.73%) which is comparable to the rest of the industry.
  • ASLE's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 4.03%, ASLE perfoms like the industry average, outperforming 42.31% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ASLE has declined.
  • The Gross Margin of ASLE (30.83%) is better than 66.67% of its industry peers.
  • ASLE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.03%
PM (TTM) 1.73%
GM 30.83%
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
ASLE Yearly Profit, Operating, Gross MarginsASLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. ASLE Health Analysis

2.1 Basic Checks

  • ASLE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for ASLE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ASLE Yearly Shares OutstandingASLE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASLE Yearly Total Debt VS Total AssetsASLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.16 indicates that ASLE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ASLE has a worse Altman-Z score (2.16) than 69.23% of its industry peers.
  • ASLE has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
  • ASLE has a better Debt to Equity ratio (0.30) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 2.16
ROIC/WACC0.17
WACC10.45%
ASLE Yearly LT Debt VS Equity VS FCFASLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 4.41 indicates that ASLE has no problem at all paying its short term obligations.
  • ASLE has a Current ratio of 4.41. This is in the better half of the industry: ASLE outperforms 76.92% of its industry peers.
  • ASLE has a Quick Ratio of 4.41. This is a bad value and indicates that ASLE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of ASLE (0.92) is worse than 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 4.41
Quick Ratio 0.92
ASLE Yearly Current Assets VS Current LiabilitesASLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. ASLE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 84.21% over the past year.
  • ASLE shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -33.12% yearly.
EPS 1Y (TTM)84.21%
EPS 3Y-33.12%
EPS 5YN/A
EPS Q2Q%77.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.02%

3.2 Future

  • Based on estimates for the next years, ASLE will show a very strong growth in Earnings Per Share. The EPS will grow by 65.07% on average per year.
  • ASLE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.36% yearly.
EPS Next Y86.51%
EPS Next 2Y65.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.09%
Revenue Next 2Y21.36%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
ASLE Yearly Revenue VS EstimatesASLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ASLE Yearly EPS VS EstimatesASLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

6

4. ASLE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.44 indicates a rather expensive valuation of ASLE.
  • Compared to the rest of the industry, the Price/Earnings ratio of ASLE indicates a rather cheap valuation: ASLE is cheaper than 93.59% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of ASLE to the average of the S&P500 Index (26.15), we can say ASLE is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 9.35, the valuation of ASLE can be described as reasonable.
  • ASLE's Price/Forward Earnings ratio is rather cheap when compared to the industry. ASLE is cheaper than 97.44% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.27. ASLE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 17.44
Fwd PE 9.35
ASLE Price Earnings VS Forward Price EarningsASLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ASLE is valued cheaply inside the industry as 89.74% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.87
ASLE Per share dataASLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ASLE's earnings are expected to grow with 65.07% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y65.07%
EPS Next 3YN/A

0

5. ASLE Dividend Analysis

5.1 Amount

  • ASLE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ASLE Fundamentals: All Metrics, Ratios and Statistics

AERSALE CORP

NASDAQ:ASLE (3/12/2026, 2:24:46 PM)

6.105

-0.33 (-5.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-05
Earnings (Next)05-05
Inst Owners59.06%
Inst Owner Change1.94%
Ins Owners2.77%
Ins Owner Change-0.1%
Market Cap288.09M
Revenue(TTM)N/A
Net Income(TTM)5.88M
Analysts45.71
Price Target8.16 (33.66%)
Short Float %2.92%
Short Ratio4.54
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)239.17%
Min EPS beat(2)-75.26%
Max EPS beat(2)553.6%
EPS beat(4)1
Avg EPS beat(4)79.68%
Min EPS beat(4)-157.67%
Max EPS beat(4)553.6%
EPS beat(8)2
Avg EPS beat(8)24.08%
EPS beat(12)3
Avg EPS beat(12)-3.77%
EPS beat(16)6
Avg EPS beat(16)24.15%
Revenue beat(2)1
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-25.64%
Max Revenue beat(2)21.94%
Revenue beat(4)2
Avg Revenue beat(4)-7.61%
Min Revenue beat(4)-27.97%
Max Revenue beat(4)21.94%
Revenue beat(8)3
Avg Revenue beat(8)-11.66%
Revenue beat(12)3
Avg Revenue beat(12)-14.22%
Revenue beat(16)6
Avg Revenue beat(16)-7.75%
PT rev (1m)0%
PT rev (3m)14.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-26.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.44
Fwd PE 9.35
P/S 0.85
P/FCF N/A
P/OCF 89.89
P/B 0.69
P/tB 0.76
EV/EBITDA 12.87
EPS(TTM)0.35
EY5.73%
EPS(NY)0.65
Fwd EY10.69%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.07
OCFY1.11%
SpS7.19
BVpS8.84
TBVpS8.02
PEG (NY)0.2
PEG (5Y)N/A
Graham Number8.34
Profitability
Industry RankSector Rank
ROA 0.91%
ROE 1.41%
ROCE 2.39%
ROIC 1.78%
ROICexc 1.8%
ROICexgc 1.93%
OM 4.03%
PM (TTM) 1.73%
GM 30.83%
FCFM N/A
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-51.13%
ROICexgc growth 5YN/A
ROICexc growth 3Y-49.58%
ROICexc growth 5YN/A
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 3.8
Cap/Depr 50.56%
Cap/Sales 2.88%
Interest Coverage 1.89
Cash Conversion 9.71%
Profit Quality N/A
Current Ratio 4.41
Quick Ratio 0.92
Altman-Z 2.16
F-Score5
WACC10.45%
ROIC/WACC0.17
Cap/Depr(3y)91.07%
Cap/Depr(5y)58.73%
Cap/Sales(3y)3.18%
Cap/Sales(5y)2.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.21%
EPS 3Y-33.12%
EPS 5YN/A
EPS Q2Q%77.78%
EPS Next Y86.51%
EPS Next 2Y65.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.02%
Revenue Next Year19.09%
Revenue Next 2Y21.36%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y264.14%
EBIT growth 3Y-38.5%
EBIT growth 5YN/A
EBIT Next Year350%
EBIT Next 3Y89.92%
EBIT Next 5YN/A
FCF growth 1Y96.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y101.93%
OCF growth 3Y-47.9%
OCF growth 5YN/A

AERSALE CORP / ASLE FAQ

What is the ChartMill fundamental rating of AERSALE CORP (ASLE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ASLE.


What is the valuation status for ASLE stock?

ChartMill assigns a valuation rating of 6 / 10 to AERSALE CORP (ASLE). This can be considered as Fairly Valued.


Can you provide the profitability details for AERSALE CORP?

AERSALE CORP (ASLE) has a profitability rating of 3 / 10.


What is the financial health of AERSALE CORP (ASLE) stock?

The financial health rating of AERSALE CORP (ASLE) is 3 / 10.


Can you provide the expected EPS growth for ASLE stock?

The Earnings per Share (EPS) of AERSALE CORP (ASLE) is expected to grow by 86.51% in the next year.